CLINICAL_TRIALS trial_result · 2015-12-14

Clinical Trial Update: Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection [Phase 2]

A Phase 2 study in patients with chronic hepatitis C virus infection, genotype 2 or 3, has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C Virus | Phase 2 | Status: COMPLETED | Results posted: 2015-12-14